Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
31/07/2025 19:49
July 31 (Reuters) - LakeShore Biopharma Co Ltd H6Z0.F: LAKESHORE BIOPHARMA CO LTD: ANTICIPATES TOTAL REVENUE IN FY2026 TO BE BETWEEN ABOUT RMB550 MILLION AND RMB650 MILLION Source text: [ID:n0001213900-25-069883] Further company coverage: H6Z0.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing